‘Wonder drug’ could delay Alzheimer’s symptoms for three years

A pioneering Alzheimer’s drug could hold back the devastating symptoms of the disease for up to three years, according to promising new research.

Scientists say donanemab not only delays memory and thinking problems but also slows the brain changes linked to Alzheimer’s, raising fresh hopes for…